Fact based stock research
PharmaSGP Holding (XTRA:PSG)

DE000A2P4LJ5

PharmaSGP Holding stock research in summary

pharmasgp.com


PharmaSGP Holding shares are more expensive than other comparable stocks. While they show above average growth, they are poor value, and are riskily financed. We recommend evaluating whether the future of the company PharmaSGP Holding is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.


Latest Obermatt Ranks


Value Rank 25
Growth Rank 87
Safety Rank 6
Combined Rank 27
Country Germany
Industry Pharmaceuticals
Index CDAX
Size class X-Small

November 3, 2022. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist
Filter Similar Stocks
Similar Top 10

Research History: PharmaSGP Holding

RESEARCH HISTORY 2019 2020 2021 2022
VALUE
VALUE n/a
n/a
9
25
GROWTH
GROWTH n/a
n/a
2
87
SAFETY
SAFETY n/a
n/a
25
6
COMBINED
COMBINED n/a
n/a
3
27

Last update of Combined Rank: 3-Nov-2022. Financial reporting date used for calculating ranks: 3-Nov-2022. Stock research history is based on the Obermatt Method. The higher the rank, the better PharmaSGP Holding is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2019 2020 2021 2022
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S) n/a
n/a
29
46
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E) n/a
n/a
52
28
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book) n/a
n/a
2
4
DIVIDEND YIELD
DIVIDEND YIELD n/a
n/a
1
63
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE n/a
n/a
9
25

Last update of Value Rank: 3-Nov-2022. Stock analysis on value ratios: The higher the rank, the lower the value ratio of PharmaSGP Holding; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2019 2020 2021 2022
REVENUE GROWTH
REVENUE GROWTH n/a
n/a
14
54
PROFIT GROWTH
PROFIT GROWTH n/a
n/a
42
STOCK RETURNS
STOCK RETURNS n/a
n/a
47
73
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH n/a
n/a
2
87

Last update of Growth Rank: 3-Nov-2022. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of PharmaSGP Holding.


Safety Metrics in Detail

SAFETY METRICS 2019 2020 2021 2022
LEVERAGE
LEVERAGE n/a
n/a
51
6
REFINANCING
REFINANCING n/a
n/a
16
1
LIQUIDITY
LIQUIDITY n/a
n/a
33
59
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY n/a
n/a
25
6

Last update of Safety Rank: 3-Nov-2022. Stock analysis on safety metrics: The higher the rank, the lower the leverage of PharmaSGP Holding and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for PharmaSGP Holding from November 3, 2022.


We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.